Matrine restrains the development of colorectal cancer through regulating the AGRN /Wnt/β‐catenin pathway
Environmental Toxicology · 2023
DOI: 10.1002/tox.23730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2023. Verfasst von Xianzhe Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Nanshi Hospital, Nanyang, China. Hauptthemen laut MEDLINE: Matrines, Colorectal Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
Background
Colorectal cancer is a common malignant digestive tract tumor. This study aimed to explore the biological role and potential underlying mechanism of matrine in colorectal cancer.
Methods
The mRNA expression of AGRN was measured using RT‐qPCR. Cell proliferation, migration, invasion and apoptosis were determined using CCK‐8, EdU, transwell assays and flow cytometry, respectively. Xenograft tumor experiment was performed to explore the action of matrine and AGRN on tumor growth in colorectal cancer in vivo. Immunohistochemistry (IHC) assay was applied for AGRN, β‐catenin, and c‐Myc expression in the tumor tissues from mice.
Results
Matrine dramatically repressed cell growth and reduced the level of AGRN in colorectal cancer cells. AGRN expression was boosted colorectal cancer tissues and cells. AGRN downregulation depressed cell proliferation, migration, invasion, and enhanced cell apoptosis in colorectal cancer cells. Moreover, matrine showed the anti‐tumor effects on colorectal cancer cells via regulating AGRN expression. AGRN knockdown could inactivate the Wnt/β‐catenin pathway in colorectal cancer cells. We found that AGRN downregulation exhibited the inhibition action in the progression of colorectal cancer by modulating the Wnt/β‐catenin pathway. In addition, matrine could inhibit the activation of the Wnt/β‐catenin pathway through regulating AGRN in colorectal cancer cells. Furthermore, xenograft tumor experiment revealed that matrine treatment or AGRN knockdown repressed the development of colorectal cancer via the Wnt/β‐catenin pathway in vivo.
Conclusion
Matrine retarded colorectal cancer development by modulating AGRN to inactivate the Wnt/β‐catenin pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Nanshi Hospital, Nanyang, China.
- Department of radiation oncology, The Fifth People's Hospital of Huai'an, Huai'an, China.
- Department of Medical Oncology, Nanshi Hospital, Nanyang, China.
- Department of Radiotherapy, Nanshi Hospital, Nanyang, China.
- Department of Neurosurgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an Second People's Hospital, Huai'an, China.
ORCID-Profile: Eryan Feng
Zitieren
APA
Li, X., Lu, Y., Wen, P., Yuan, Y., Xiao, Z., Shi, H., & Feng, E. (2023). Matrine restrains the development of colorectal cancer through regulating the AGRN /Wnt/β‐catenin pathway. Environmental Toxicology. https://doi.org/10.1002/tox.23730
Vancouver
Li X, Lu Y, Wen P, Yuan Y, Xiao Z, Shi H, et al. Matrine restrains the development of colorectal cancer through regulating the AGRN /Wnt/β‐catenin pathway. Environmental Toxicology. 2023. doi:10.1002/tox.23730
BibTeX
@article{Li2023,
author = {Li, Xianzhe and Lu, Ye and Wen, Penghao and Yuan, Yan and Xiao, Zhenghong and Shi, Hengwei and Feng, Eryan},
title = {Matrine restrains the development of colorectal cancer through regulating the AGRN /Wnt/β‐catenin pathway},
journal = {Environmental Toxicology},
year = {2023},
doi = {10.1002/tox.23730}
}
EUVIMED